NEW YORK (GenomeWeb) – BioMérieux reported today that its fourth quarter revenues rose 10 percent year over year both on a reported and adjusted basis.
For the three months ended Dec. 31, BioMérieux reported revenues of €672.4 million ($765.6 million), up from €613.8 million in the prior-year period.